Teest Headline Here
Blurby blurb.Blurby blurb.Blurby blurb.Blurby blurb.Blurby blurb.Blurby blurb.Blurby blurb.Blurby blurb.Blurby blurb.Blurby blurb.Blurby blurb.Blurby blurb.Blurby blurb.Blurby blurb.
This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file.
This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file. This is the body if the file.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
